DavidRByrdMD
General Surgery • Seattle, WABreast, Endocrine, Surgical Oncology (Other than Breast)
Associate Professor of Surgery, University Wash
Overview of Dr. Byrd
Dr. David Byrd, MD is a general surgeon in Seattle, Washington. He is currently licensed to practice medicine in Washington and Texas. He is affiliated with UW Medicine/University of Washington Medical Center, Seattle Cancer Care Alliance, and UW Medicine/Harborview Medical Center.
Office
1959 Ne Pacific St
Seattle, WA 98195- Is this information wrong?
Education & Training
University of Washington School of MedicineResidency, Surgery, 1982 - 1987
Tulane University School of MedicineClass of 1982
Certifications & Licensure
TX State Medical License 1990 - 1992
WA State Medical License 1983 - 2022- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery Start of enrollment: 2015 Jul 01
Publications & Presentations
PubMed
- 8 citationsClinical benefit of baseline imaging in Merkel cell carcinoma: Analysis of 584 patientsN. Singh, Nora A. Alexander, K. Lachance, C. Lewis, Aubriana M. McEvoy, Gensuke Akaike, David R. Byrd, Sanaz Behnia, Shailender Bhatia, Kelly G. Paulson, Paul Nghiem> ;Journal of The American Academy of Dermatology. 2021 Feb 1
- 11 citationsNarrow excision margins are appropriate for Merkel cell carcinoma when combined with adjuvant radiation: Analysis of 188 cases of localized disease and proposed manage...Erica S. Tarabadkar, Teresa Fu, K. Lachance, Daniel S. Hippe, Thomas Pulliam, Hannah Thomas, Janet Y. Li, C. Lewis, Coley Doolittle-Amieva, David R. Byrd, Jeremy T. Ka...> ;Journal of The American Academy of Dermatology. 2021 Feb 1
- 7 citationsCurrent and future cancer staging after neoadjuvant treatment for solid tumorsDavid R. Byrd, James D. Brierley, Thomas P. Baker, Daniel C. Sullivan, Donna M. Gress> ;CA: A Cancer Journal for Clinicians. 2021 Mar 1
- Join now to see all
Journal Articles
- Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients with Merkel Cell CarcinomaUpendra Parvathaneni, David M Koelle, David Byrd, Shailender Bhatia, Michi Shinohara, Clinical Cancer Research
Professional Memberships
- Member
- Member
Hospital Affiliations
- Seattle Cancer Care AllianceSeattle, Washington
UW Medicine/Harborview Medical CenterSeattle, Washington
UW Medicine/University of Washington Medical CenterSeattle, Washington
Insurance Accepted
- Aetna Choice POS II
BCBS Blue Card PPO
BCBS Illinois PPO
BCBS North Carolina BlueOptions PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First ChoiceGreat West PPO
Health Net Oregon PPO
ODS Network
Premera BCBS Heritage & Heritage Plus 1
Providence Health System Personal Option
Regence Washington - Preferred Provider Network
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
